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Risk factorsSubcortical vascular dementia or cerebral small vessel disease is a common cause of disability in the elderly.
On magnetic resonance imaging the disease is manifested as white matter lesions, lacunes and microbleeds.
Its etiology is complex, with age and hypertension as established risk factors. The heritability of white matter
lesions is constantly high over different populations. Linkage studies identiﬁed several loci for these lesions
however no genes responsible for the linkage signals had been identiﬁed so far. Results from genetic associ-
ation studies using the candidate gene approach support the role of APOE, the renin–angiotensin system, as
well as the Notch3 signaling pathway in the development of subcortical vascular dementia. The recent
genomegenome wide association study on white matter lesions identiﬁed a novel locus on chromosome
17q25 harboring several genes such as TRIM65 and TRIM47 which pinpoints to possible novel mechanisms
leading to these lesions.
© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Subcortical vascular dementia (VaD) results from cerebral small
vessel disease leading to ischemic and hemorrhagic brain tissue dam-
age that can be observed on magnetic resonance imaging (MRI). Such
brain lesions are white matter lesions (WML), lacunes and microbleeds
(MB).WML are seen on T2/FLAIRweightedMRI as areas of high signal in-
tensity of variable extent. (Fig. 1A–D). Mild periventricular lines and caps
as well as punctate deep lesions are of non-ischemic origin, while early
conﬂuent and conﬂuent lesions represent ischemic damage ranging
from incomplete to complete tissue loss (Fazekas et al., 1993). The preva-
lence of any WML ranges between 40 and 95%, depending on the study
population (van Dijk et al., 2002). Conventional risk factors such as age
and hypertension explain only a small proportion of the occurrence of
WML (O'Brien et al., 2003). Lacunes are observed on T2/FLAIR weighted
MR images as 3 to 15 mm abnormalities with CSF-equivalent signal in-
tensity (Koch et al., 2011) (Fig. 1E). Their frequency ranges between 6
and 20% (van Dijk et al., 2002). The third lesion type is MB seen as
hypointense or black spots on susceptibility or T2* weighted MR images
due to paramagnetic effects of hemosiderin deposits at the location of
the bleeding (Greenberg et al., 2009) (Fig. 1F). In the Rotterdam Scangy and Biochemistry, Center of
hgasse 21, 8010 Graz, Austria.
Schmidt).
NC-ND license.Study, prevalence of MB increased strongly with age, ranging from 6.5
to 35.7%.
2. Heritability of cerebral small vessel disease
Although several monogenic forms of cerebral small vessel disease
with early onset have been described, the majority of patients with
subcortical VaD represents sporadic cases with enhanced aggregation
in families but without a clear Mendelian pattern of inheritance. The
heritability of a trait gives the proportion of the total phenotypic var-
iance (Vp) in the population which can be explained by genetic differ-
ences among individuals (Vg). Importantly, the heritability index is a
quotient (h2=Vg/Vp) and its estimate is high, when there is a strong
phenotypic variability due to genetic factors, as well as when there is
low phenotypic variability due to environmental factors in a popula-
tion. Therefore heritability indices strictly apply to the population
they have been estimated for. Heritability estimates for these age-
related forms have been reported for WML in elderly male twins
(Carmelli et al., 1998) in a large population based sample of middle
aged–elderly sibships (Atwood et al., 2004), within non-Hispanic
white and black hypertensive siblings (Turner et al., 2004), and in sib-
lings discordant for Alzheimer disease (Cuenco et al., 2008). In spite of
major differences in study design, heritability estimates were compara-
ble among these studies, andwerewithin the range of 50–80%. The her-
itability of WML may however be dependent on gender and age as
reported by the Framingham study with young women having the
Fig. 1. Different lesion types commonly found on MRI scans of elderly people (arrows): (A–E) show Fluid Attenuated Inversion Recovery (FLAIR) sequences where white matter
lesions (WML) appear as areas of high signal intensity while cerebrospinal ﬂuid (CSF) signal is suppressed. (A) So-called “caps” located symmetrically around the anterior horns
of both lateral ventricles. (B) Punctate WML in the centrum semiovale (CS) of the right hemisphere. (C) Early conﬂuent and (D) conﬂuent WML in the left CS. (E) Lacune seen
as CSF-isointense lesion surrounded by a small hyperintense rim in the right CS. (F) shows a T2* weighted MRI sequence that is sensitive to susceptibility effects of hemosiderin.
Spots of low signal intensity correspond to microbleeds in the left basal ganglia and thalamus.
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analyses explore the genetic correlation (rg) between traits, which
gives the proportion of variance that two traits share due to common
genetic factors. The GENOA study showed signiﬁcant genetic correlations
(rg) betweenWML andmean arterial pressure both inwhites (rg=0.61)
and in blacks (rg=0.40) and with pulse pressure in blacks (0.29;
Pb .001). This indicates common genetic components between WML
and blood pressure (Turner et al., 2004). Bivariate heritability analyses
also suggested common genetic inﬂuences on WML volume and the
volume of speciﬁc brain regions such as frontal (rg=0.30) and parietal
lobe (rg=−0.39) (DeStefano et al., 2009). Heritability estimates for
lacunes and for MB are not available so far.
In order to identify genetic variants contributing to subcortical
VaD both association and linkage studies have been performed.
These studies mainly focused on WML, but some candidate gene
based association studies also investigated lacunes and MB.
3. Linkage studies
So far signiﬁcant logarithm of the odds (LOD) scores forWML have
been found at 4 cM on chromosome 4 (DeStefano et al., 2006;
Seshadri et al., 2007), in healthy elderly white subjects, and at chro-
mosome 1q24 in hypertensive sibships (Turner et al., 2009). Sugges-
tive LOD scores by these studies have been reported at 95 cM on
chromosome 17 (LOD=1.78) (DeStefano et al., 2006), at 118 cM on
chromosome 11, and at 13 cM on chromosome 21 in white, and at
36 cM on chromosome 22 as well as at 58 cM on chromosome 21 in
black subjects (Turner et al., 2009). Bivariate linkage studies identi-
ﬁed signiﬁcant (chromosome 1q24) and suggestive (chromosome
1q42, 10q22–q26, 15q26) shared loci for WML volumes and blood
pressure measurements, such as pulse pressure and systolic blood
pressure, indicating the presence of genes with pleiotropic effects at
these regions (Kochunov et al., 2010; Turner et al., 2009).4. Association studies
Association studies aim to identify genetic variants explaining
phenotypic variations in a trait or in susceptibility to a disease in
the population. The most frequently investigated genetic variants
are the single nucleotide polymorphisms (SNPs), which are bi-allelic
variants in the human genome involving a nucleotide exchange. The
phenotypes investigated by association studies are either qualitative
or quantitative. In case of dichotomized outcomes the effect size esti-
mates of the variant is given as the odds ratio (OR) in those carrying
the variant allele compared to non-carriers. If an observed genetic as-
sociation is true, then it implies that either the investigated variant is
causal (direct association) or there is a causal variant in linkage dis-
equilibrium with the investigated one in its neighborhood (indirect
association). Importantly, observed associations in one sample must
be replicated in independent samples in order to reduce the likeli-
hood of false positive ﬁndings, which had discredited association
studies in early days. Association studies performed according to pub-
lished guidelines ensure high quality and have substantially contrib-
uted to our understanding of subcortical VaD. During the last two
decades numerous association studies using the candidate gene ap-
proach have focused on pathways hypothesized to be involved in
the pathogenesis of cerebral small vessel disease. According to a re-
cent meta-analyses 46 candidate gene studies investigating variants
in 19 genes have been performed (Paternoster et al., 2009). Markus
(2008) reviewed studies investigating genes involved in vascular dys-
function in cerebral small vessel disease such as EDN1, MHTFR, and
NOS3 (GenBank ID 1906, 4524, 4846). Due to small sample size of
the studies and lack of replications, there is little statistical evidence
presently that these genes harbor causal variants for subcortical
VaD. Recently hypothesis free genome wide approaches became af-
fordable and identiﬁed novel genetic variants in pathways not being
suspected to be involved in the development of these lesions
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ly supported by replication studies or functional data and discuss the
ﬁndings of the ﬁrst genome wide association (GWA) study (Table 1).
4.1. APOE
APOE (GenBank ID 348) is the only gene, which had been investi-
gated in all three MRI correlates of subcortical VaD. The APOE E4
allele was reported to be associated both with the extent and the pro-
gression of WML (Godin et al., 2009; Leeuw et al., 2004). Contrarily,
the Austrian Stroke Prevention Study found a higher prevalence of
WML and lacunar infarcts in carriers of the E2 allele (Schmidt et al.,
1997). The effect of APOE variants on WML may depend on vascular
risk factors such as the presence hypertension (Leeuw et al., 2004).
Homozygosity for the E4 allele was also signiﬁcantly associated with
the presence of lacunes in an isolated population (Schuur et al.,
2011). In the Rotterdam study, the presence of APOE E4 allele en-
hanced the risk for cerebral MB (Poels et al., 2010), but this ﬁnding
is controversial (Lemmens et al., 2007).
4.2. The renin–angiotensin system (RAS)
Genes coding for the RAS are excellent candidates for cerebral
small vessel disease as RAS is a major regulator of systemic blood
pressure, and of cerebral blood ﬂow. Plasma angiotensinogen (AGT,
GenBank ID 183) synthesized by the liver is processed to angiotensin
II (Ang II) by the serial action of renin and angiotensin-converting en-
zyme (ACE GenBank ID 1636). Ang II exerts its effect through the an-
giotensin receptors (AGTR GenBank ID 185). The association of ACE I/
D polymorphism with WML has been investigated in nine studies in-
cluding 2396 individuals and the DD genotype remained a signiﬁcant
predictor of WML (OR=1,95; 95% CI 1,09:3,48) upon meta-analysisTable 1
Summary of association studies on white matter lesions, lacunes and microbleeds discusse
Phenotype Gene/ref seq Gene
ID
SNP rs number Risk allele OR/p value
WML burden ACE (1636) I/D D/D OR=1.95, 95
WML presence AGT (183) Promoter
haplotype
B/B or B+/A− OR=8.0 P=
WML burden M235T/rs699 235T NS
WML burden M235T/rs699 235T P=0.01
WML progression AGTR1 (185) A1166C/rs5186 1166C P=0.0002 in
WML progression AGTR2 (11609) C3123A 3123A P=0.014 in
WML burden APOE (348) ε2/ε3/ε4 ε4 carrier P=0.016 in
WML burden ε2/ε3/ε4 ε4 carrier P=0.003
WML and lacunes
presence
ε2/ε3/ε4 ε2/ε3 genotype OR 3.0.
WML presence ε2/ε3/ε4 ε4 carrier NS
Lacunes APOE (348) ε2/ε3/ε4 ε4+/ε4+ OR 4.7 p=0
Microbleeds APOE (348) ε2/ε3/ε4 ε4 carrier OR=1.35, 95
WML presence NOTCH3 (4854) rs10404382 1036+846G>T OR 1.8 p=0
OR 3,2 p=0
hypertensive
WML progression rs10404382 1036+846G>T β=0.087 p=
β=0.136 p=
hypertensive
Microbleeds SORL1 (6653) rs2282649. 5239+73TT OR 6.87 p=
WML burden TRIM 47 (91107) rs3744017 A p=7.3×10−
WML burden TRIM 65 (201292) rs3744028 C p=4.0×10−
WML burden WBP2 (23558) rs11869977 G p=5.7×10−
WML=white matter lesions; OR=odds ratio; 95% CI=95% conﬁdence interval; β=regres(Paternoster et al., 2009). The most frequently investigated single nu-
cleotide polymorphism (SNP) in the AGT gene is the M235T.
Meta-analyses of 6 candidate gene studies including 2702 individuals
showed no effect of this SNP on WML (Paternoster et al., 2009). In
contrast, linkage studies repeatedly implicated the AGT locus (1q42)
(Kochunov et al., 2010; Turner et al., 2009) and the recent GWA
study had replicated the association between the 235T allele and
WML (Fornage et al., 2011). It is likely that the 235T SNP by itself is
not causal, and functional variants in linkage disequilibrium are re-
sponsible for these ﬁndings. One such variant might be a haplotype
(-6:a, -20:c, -153:g, -218:g, positions relative to transcriptional start
site) at the AGT promoter. This haplotype was ﬁrst described by the
Austrian Stroke Prevention Study and was signiﬁcantly related to
the presence of severe WML (Schmidt et al., 2001). The association
was independent of hypertension and the haplotype enhanced the
basal transcriptional activity of the AGT promoter in astrocytes but not
in hepatocytes suggesting that the association ismediated by an altered
activity of the cerebral and not the systemic RAS (Schmidt et al., 2004).
Recently, a longitudinal study reported that progression rate ofWML in
elderly men is inﬂuenced by polymorphisms in the AGTR1 and AGTR2
genes. Homozygotes for the 1166A allele at AGTR1 showed less change
over time than 1166C carriers (Taylor et al., 2010).
4.3. NOTCH3
CADASIL is caused by mutations in the NOTCH3 (GenBank ID
4854) gene (Joutel et al., 1996), which plays a central role in the func-
tional and structural integrity of small arteries (Domenga et al.,
2004). Recently sequencing of the NOTCH3 gene in the Austrian
Stroke Prevention Study showed that this gene is highly variable in
the elderly with both common and rare SNPs spreading over the
gene (Schmidt et al., 2011). Common SNPs (rs1043994, rs10404382,d in the text.
Sample Reference
% CI=1.09–3.48 Meta-analysis of 46 studies Paternoster et al.,
2009
0.003 Cohort study in elderly Caucasian Schmidt et al., 2001
Meta-analysis of 6 studies Paternoster et al.,
2009
Meta‐analyses of GWAS in elderly
Caucasian
Fornage et al., 2011
males Depressed and non-depressed elderly
Caucasian
Taylor et al., 2010
males Depressed and non-depressed elderly
Caucasian
Taylor et al., 2010
hypertensives. Cohort study elderly Caucasian Leeuw et al., 2004
Cohort study elderly Caucasian Godin et al., 2009
Cohort study elderly Caucasian Schmidt et al., 1997
Meta-analysis of 24 studies Paternoster et al.,
2009
.04 Genetic isolate, elderly hypertensives Schuur et al., 2011
% CI=1.10–1.65 Cohort study elderly Caucasian Poels et al., 2010
.02;
.002 in
s
Cohort study elderly Caucasian Schmidt et al., 2011
0.05;
0.013 in
s;
0.005 Genetic isolate, elderly hypertensives Schuur et al., 2011
9 Meta‐analyses of GWAS in elderly
Caucasian
Fornage et al., 2011
9 Meta‐analyses of GWAS in elderly
Caucasian
Fornage et al., 2011
9 Meta‐analyses of GWAS in elderly
Caucasian
Fornage et al., 2011
sion coefﬁcient; GWAS=genome-wide association study, NS=non signiﬁcant.
876 H. Schmidt et al. / Experimental Gerontology 47 (2012) 873–877rs10423702, rs1043997) were signiﬁcantly associated with the presence
and the progression of WML. The association was conﬁned to hyperten-
sives and was replicated in the Cohorts for Heart and Ageing Research
inGenomic Epidemiology Consortium(CHARGE) in an independent sam-
ple of 4773 stroke-free hypertensive elderly individuals of European de-
scent. Beside the common SNPs there were 6 non-synonymous rare
SNPs (H170R, P496L, V1183M, L1518M, D1823N and V1952M) in this
study, which were detected only in subjects with severe WML and
which were predicted to be functional by protein modeling tools. Impor-
tantly none of these SNPs affected a cysteine residue and none of the sub-
jects carrying these mutations had MRI signs typical of CADASIL. The
results on NOTCH3 resembles other studies on complex traits, such as
dyslipidemia where genes carrying common variants associated with
modest effect in the population also carry rare variants with large effects
segregating in families.
4.4. Genome wide association study
The ﬁrst GWA study on WML was performed within the CHARGE
consortium (Fornage et al., 2011), including 9361 elderly individuals
of European descent from 7 community-based cohort studies: the
Aging Gene–Environment Susceptibility-Reykjavik Study, the Athero-
sclerosis Risk in Communities Study, the Austrian Stroke Prevention
Study, the Cardiovascular Health Study, the Framingham Heart
Study, and 2 cohorts from the Rotterdam Study. Genome wide signif-
icant association was identiﬁed for 6 SNPs on chromosome 17q25.
The ﬁndings had been replicated in an independent sample of 1607
AGES-Reykjavik participants and in 1417 elderly white participants
from the 3C-Dijon Study in the original report (Fornage et al., 2011)
and in 1677 persons of the Rotterdam Study III (Verhaaren et al.,
2011). In the ~100 kb long region on chromosome 17 there are sever-
al genes with diverse functions such as the 2 tripartite motif-
containing genes (TRIM65 and TRIM47 GenBank ID 201292, 91107)
the WW domain binding protein 2 gene (WBP2 GenBank ID 23558),
the mitochondrial ribosomal protein L38 gene (MRPL38 GenBank ID
64978), the Fas-binding factor 1 gene (FBF1 GenBank ID 217335), the
acyl-coenzyme A oxidase 1 gene (ACOX1 GenBank ID 51) and the
C-Elegans homolog (UNC13D GenBank ID 201294) gene whichmay ac-
count for the association. The study also reported 3 additional SNPswith
highly suggestive p-values of b5∗10−5 which were located within
genes coding for the polyamine-modulated factor 1 gene (PMF1
GenBank ID11243), the collagen type XXV alpha gene (COL25A1
GenBank ID84570), and themethylenetetrahydrofolate dehydrogenase
1 gene (MTHFD1 GenBank ID 4522).
5. Summary
The last decade of research on the genetics of cerebral small vessel
disease showed that this phenotype is highly heritable over different
populations and subgroups. Candidate gene studies provided strong
evidence for at least three pathways involved, namely the RAS, the
NOTCH3 signaling pathway and pathways related to APOE. These
pathways play an important role in the normal functioning of the
neurovascular unit by ensuring dynamic communication between as-
trocytes, vascular smoothmuscle cells, pericytes and endothelial cells.
It is conceivable that mutations within these genes interfere with nor-
mal cellular communications and lead to a dysfunction of the neuro-
vascular unit, which in turn leads to impaired vasoregulation, cerebral
autoregulation, and blood brain barrier permeability. This may ulti-
mately result in ischemic parenchymal damagewithmyelin rarefaction
as histopathologically observed in areas ofWML. The recent GWA study
was successful in identifying common variants at chromosome 17, and
pinpointed to possible novelmechanisms leading toWML. Although as-
sociation studies had been successful in identifying many common ge-
netic variants, these variants have small effect sizes, odds ratios are
typically below 2, and are therefore not useful in clinical settings.Common variants identiﬁed so far also explain only a small proportion
of the heritability. The same is true for genetic variants that have been
identiﬁed for other dementia types including Alzheimer's disease.
Other than in dementia of the Alzheimer type in which many of the
identiﬁed susceptibility genes and even of loci identiﬁed in GWA stud-
ies have been replicated by multiple studies with large sample sizes
(Paulson and Igo, 2011), the genetic architecture of vascular dementia
and its subtypes is less well explored. Many of the reported genetic as-
sociations seen with vascular dementia-related phenotypes rely on
small to mid-sized single studies and replication will be mandatory in
order to judge on the robustness of these ﬁndings.
This missing heritability might be explained by the fact, that the
association studies conducted were designed to test common SNPs
with minor allele frequency of ≥5%. Other kinds of genetic variations
such as rare or even individual SNPs, copy number variations and epi-
genetic modiﬁcations though maybe equally important, have not yet
been targeted. An alternative to the “common disease common vari-
ants” hypotheses is the “common disease rare variant” hypothesis
which supposes that rare variants (minor allele frequency ≤1–5%)
with large effect size (OR>2) segregating in families may substantial-
ly contribute to the heritability of common diseases. Linkage studies,
which have the highest power to test this hypothesis, had detected
signiﬁcant loci for WML, but the causal variants responsible for the
linkage signals have not yet been identiﬁed. With the advent of
next generation sequencing methods and the comprehensive cata-
log of rare variants by the 1000 Genomes Project (http://www.
1000genomes.org/page.php), sequencing these regions in large
number of individuals became feasible, and we expect that rare
causal variants with a large effect size will be identiﬁed in the
future.
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